GlassScriptPrepare for your visit
Caroline Kwon
Nephrology (Internal Medicine) · Fairfax, VA · NPI 1285912857
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,021.96
in general payments reported to CMS, 2019-2025 · $143 in 2025
The $143 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Who reported paying
General payments only, top 6 by amount.
- Ani Pharmaceuticals, INC. $336.60
- Mallinckrodt Hospital Products INC. $190.93
- Gilead Sciences, INC. $189.48
- Otsuka America Pharmaceutical, INC. $180.98
- Teva Pharmaceuticals USA, INC. $138.60
- Aurinia Pharma U.S., INC. $121.26
Drugs and devices associated with these payments
Purified Cortrophin Gel Acthar Lupkynis Gazyva Rivfloza Kerendia Furoscix Tarpeyo Fabhalta
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Caroline Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/2766235/caroline-kwon